| PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy G Osman, J Rodriguez, SY Chan, J Chisholm, G Duncan, N Kim, AL Tatler, ... Journal of controlled release 285, 35-45, 2018 | 222 | 2018 |
| The mucus barrier to inhaled gene therapy GA Duncan, J Jung, J Hanes, JS Suk Molecular Therapy 24 (12), 2043-2053, 2016 | 204 | 2016 |
| Protein nanocages that penetrate airway mucus and tumor tissue X Huang, J Chisholm, J Zhuang, Y Xiao, G Duncan, X Chen, JS Suk, ... Proceedings of the National Academy of Sciences 114 (32), E6595-E6602, 2017 | 139 | 2017 |
| Barriers to inhaled gene therapy of obstructive lung diseases: A review N Kim, GA Duncan, J Hanes, JS Suk Journal of Controlled Release 240, 465-488, 2016 | 139 | 2016 |
| Microstructural alterations of sputum in cystic fibrosis lung disease GA Duncan, J Jung, A Joseph, AL Thaxton, NE West, MP Boyle, J Hanes, ... JCI insight 1 (18), e88198, 2016 | 106 | 2016 |
| Mucin biopolymers and their barrier function at airway surfaces D Song, D Cahn, GA Duncan Langmuir 36 (43), 12773-12783, 2020 | 87 | 2020 |
| A rational approach to form disulfide linked mucin hydrogels K Joyner, D Song, RF Hawkins, RD Silcott, GA Duncan Soft Matter 15 (47), 9632-9639, 2019 | 83 | 2019 |
| Computational design of nanoparticle drug delivery systems for selective targeting GA Duncan, MA Bevan Nanoscale 7 (37), 15332-15340, 2015 | 81 | 2015 |
| Disulfide disruption reverses mucus dysfunction in allergic airway disease LE Morgan, AM Jaramillo, SK Shenoy, D Raclawska, NA Emezienna, ... Nature communications 12 (1), 249, 2021 | 75 | 2021 |
| An adeno-associated viral vector capable of penetrating the mucus barrier to inhaled gene therapy GA Duncan, N Kim, Y Colon-Cortes, J Rodriguez, M Mazur, SE Birket, ... Molecular Therapy Methods & Clinical Development 9, 296-304, 2018 | 71 | 2018 |
| MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium D Song, E Iverson, L Kaler, A Boboltz, MA Scull, GA Duncan Science Advances 8 (47), eabq5049, 2022 | 57 | 2022 |
| Neutrophil extracellular traps increase airway mucus viscoelasticity and slow mucus particle transit RS Linssen, G Chai, J Ma, AB Kummarapurugu, JBM van Woensel, ... American journal of respiratory cell and molecular biology 64 (1), 69-78, 2021 | 52 | 2021 |
| Anomalous silica colloid stability and gel layer mediated interactions JL Bitter, GA Duncan, DJ Beltran-Villegas, DH Fairbrother, MA Bevan Langmuir 29 (28), 8835-8844, 2013 | 51 | 2013 |
| Influenza A virus diffusion through mucus gel networks L Kaler, E Iverson, S Bader, D Song, MA Scull, GA Duncan Communications biology 5 (1), 249, 2022 | 47 | 2022 |
| Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation HP Patil, D Freches, L Karmani, GA Duncan, B Ucakar, JS Suk, J Hanes, ... Journal of Controlled Release 272, 62-71, 2018 | 47 | 2018 |
| Inhaled drug delivery for the targeted treatment of asthma A Boboltz, S Kumar, GA Duncan Advanced drug delivery reviews 198, 114858, 2023 | 46 | 2023 |
| Modeling airway dysfunction in asthma using synthetic mucus biomaterials D Song, E Iverson, L Kaler, S Bader, MA Scull, GA Duncan ACS biomaterials science & engineering 7 (6), 2723-2733, 2021 | 46 | 2021 |
| Microrheology for biomaterial design K Joyner, S Yang, GA Duncan APL bioengineering 4 (4), 2020 | 43 | 2020 |
| Leveraging 3D model systems to understand viral interactions with the respiratory mucosa E Iverson, L Kaler, EL Agostino, D Song, GA Duncan, MA Scull Viruses 12 (12), 1425, 2020 | 36 | 2020 |
| National Heart, Lung, and Blood Institute workshop summary: enhancing opportunities for training and retention of a diverse biomedical workforce GA Duncan, A Lockett, LR Villegas, S Almodovar, JL Gomez, SC Flores, ... Annals of the American Thoracic Society 13 (4), 562-567, 2016 | 36 | 2016 |
